GgoogleUS first seen 12 h ago, last 11 h ago, peak #5

Retatrutide shows up to 25% weight loss in trial

Original: retatrutide

Retatrutide, an experimental obesity drug from Eli Lilly, is drawing attention after trial results showed participants losing up to 25% of their body weight, making it potentially the most powerful obesity drug tested to date. Coverage, including Ars Technica's report on the findings, is fueling discussion about how it might compare to established treatments like tirzepatide and semaglutide.

Why now: New trial results suggest retatrutide could outperform current obesity medications, prompting widespread interest.

RetatrutideEli LillyArs Technica

Open on google →

Evidence

• Lilly's experimental drug cuts weight by 21% in diabetes trial · Reuters
• Most powerful obesity drug yet: People lost up to 25% of weight in trial · Ars Technica

Elsewhere

• GgoogleGB #10 · 7 h ago
• GgoogleBR #7 · 9 h ago

API: https://socialmediatrends-api.osmike.com/v1/trends/415637